WHO Chief: Distribution of Vaccines, Not Their Creation, is Key Challenge in COVID-19 Fight
World Health Organization director general Tedros Adhanom said Monday that the distribution of a vaccine for the COVID-19, not its development, is the key challenge in the global fight against the contagious disease caused by the novel coronavirus.
“The ultimate measure of success will not be how fast we can develop tools. It will be how equally we can distribute them. None of us can accept a world in which some people are protected while others remain exposed,” the WHO chief said, speaking at a fundraising conference Monday which aims to raise at least 7.5 billion euros ($8.2 billion) for research into a vaccine and treatments for the coronavirus.
The US is not taking part in the event, which is also being attended by United Nations General Secretary Antonio Guterres.
Guterres called for the development and production of inexpensive testing kits, vaccines and treatments. “These new tools will help us to fully control the pandemic and must be treated as global public goods available and affordable for all,” he said.
Scientists from around the world, including Russia, China, the United States and Europe have been working on potential vaccines against the virus since January, sequencing its genome and beginning lab testing. Questions remain however regarding when a safe COVID-19 vaccine can be delivered to market, with many observers believing it could take up to 18 months, or possibly even longer.
US President Donald Trump has made a more optimistic prediction, however, saying Sunday that he believed a vaccine would be ready “by the end of this year.”
Organizers of Monday’s virtual fundraising conference include the European Union, the UK, Norway, Canada, Japan and Saudi Arabia. Ahead of the conference, leaders signed an open letter emphasizing their support for global vaccination efforts.
“We support the WHO and we are delighted to join forces with experienced organizations such as the Bill and Melinda Gates Foundation and the WellCome Trust,” the letter noted.
“If we can develop a vaccine that is produced by the world, for the whole world, this will be a unique global public good of the 21st century,” the appeal added.